MBA DVM - AstraZeneca PLC CEO Director
| ZEG Stock | EUR 128.30 0.85 0.66% |
Insider
MBA DVM is CEO Director of AstraZeneca PLC
| Age | 64 |
| Phone | 44 20 3749 5000 |
| Web | https://www.astrazeneca.com |
AstraZeneca PLC Management Efficiency
The company has return on total asset (ROA) of 0.0555 % which means that it generated a profit of $0.0555 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0863 %, meaning that it generated $0.0863 on every $100 dollars invested by stockholders. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Monica Melancon | Wyndham Hotels Resorts | 55 | |
| Koichi Kondo | Japan Medical Dynamic | 56 | |
| Yasuaki Hidaka | Japan Medical Dynamic | 53 | |
| Michael Franz | Compugroup Medical SE | N/A | |
| Matt Capuzzi | Wyndham Hotels Resorts | N/A | |
| Alexander Weimer | Compugroup Medical SE | N/A | |
| Scott Lepage | Wyndham Hotels Resorts | 56 | |
| Katsuhiko Seshita | Japan Medical Dynamic | 60 | |
| MBA LLM | Compugroup Medical SE | 51 | |
| Angela Teufer | Compugroup Medical SE | 50 | |
| Michele Allen | Wyndham Hotels Resorts | 48 | |
| Lisa Checchio | Wyndham Hotels Resorts | 42 | |
| Paul Cash | Wyndham Hotels Resorts | 53 | |
| Toshiyuki Hironaka | Japan Medical Dynamic | 61 | |
| Hannes Reichl | Compugroup Medical SE | 47 | |
| Nicola Rossi | Wyndham Hotels Resorts | 56 | |
| David DeCecco | Wyndham Hotels Resorts | N/A | |
| Emanuele Mugnani | Compugroup Medical SE | 53 | |
| Claudia Thom | Compugroup Medical SE | 52 | |
| Oliver Bruzek | Compugroup Medical SE | N/A | |
| Masao Okawa | Japan Medical Dynamic | 67 | |
Management Performance
| Return On Equity | 0.0863 | |||
| Return On Asset | 0.0555 |
AstraZeneca PLC Leadership Team
Elected by the shareholders, the AstraZeneca PLC's board of directors comprises two types of representatives: AstraZeneca PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AstraZeneca. The board's role is to monitor AstraZeneca PLC's management team and ensure that shareholders' interests are well served. AstraZeneca PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AstraZeneca PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Marc Dunoyer, CEO Officer | ||
| Chris Sheldon, Head Relations | ||
| Pam Cheng, EVP Board | ||
| MBA DVM, CEO Director | ||
| Gonzalo Vina, Head Relations | ||
| Aradhana MD, CFO Director | ||
| Menelas Pangalos, EVP Board | ||
| Katarina Ageborg, Chief Sustainability | ||
| Jeffrey Pott, G Officer | ||
| Ruud Dobber, Exec Unit |
AstraZeneca Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AstraZeneca PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0863 | |||
| Return On Asset | 0.0555 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 228.75 B | |||
| Shares Outstanding | 1.55 B | |||
| Shares Owned By Insiders | 0.22 % | |||
| Shares Owned By Institutions | 47.60 % | |||
| Price To Earning | 38.93 X | |||
| Price To Book | 6.17 X |
Currently Active Assets on Macroaxis
Other Information on Investing in AstraZeneca Stock
AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.